CORONAVIRUS NEWS
New findings on COVID immunity
‘Immune imprinting’ by different SARS-CoV-2 spike sequences from variants and vaccines means we now have diverse patterns of protection against new variants.
COVID-19 became much more lethal in late 2020
A new statistical analysis supports beliefs that COVID-19 became more lethal in the UK, in late 2020, while also suggesting that multiple factors (not just the alpha variant of the virus that causes COVID-19) were to blame.
Study finds gradual increase in COVID risk after second vaccine
A study published by The BMJ finds a gradual increase in the risk of COVID-19 infection from 90 days after receiving a second dose of the Pfizer-BioNTech vaccine.
Pregnant women urged to have COVID jab
Medical experts are urging pregnant women to get their COVID-19 vaccine as soon as possible, as new data published by the UK Health Security Agency (UKHSA) provides further evidence that the vaccines are safe for this group.
Sodexo awarded contract for COVID testing
Sodexo has become the sole provider of assisted COVID-19 testing at regional test sites as part of the NHS Test and Trace programme.
CPAP for COVID-19 not linked to heightened infection risk
The use of non-invasive breathing support, commonly known as CPAP or HFNO, to treat moderate to severe COVID-19 infection, isn’t linked to a heightened infection risk, as currently thought.
Potential new treatment for COVID-19 identified
Researchers have identified a potential new treatment that suppresses the replication of SARS-CoV-2, the coronavirus that causes COVID-19.
Test and Trace: “muddled, overstated and eye-wateringly expensive”
A damning report published by the Public Accounts Committee says that “NHS Test and Trace has not achieved its main objective to help break chains of COVID-19 transmission and enable people to return towards a more normal way of life”.
1.6 million people get lifesaving booster
Nearly 1.6 million booster jabs have been delivered over the past seven days. Last week also saw record bookings for boosters using the National Booking Service with nearly 900,000 people booking in their booster jab.
New antivirals could be rolled out this winter
Thousands of vulnerable patients could be taking ground-breaking COVID-19 antivirals this winter after the Government announced deals to secure two new treatments.
COVID-19-discovery could predict patient death or hospitalisation
In a new study, researchers from University of Copenhagen present what could be a much-needed helping hand to fight COVID-19.
43,000 people may have been given a false negative PCR test result
Testing operations by the Immensa Health Clinic, Wolverhampton, have been suspended following an investigation into reports of people receiving negative PCR test results after they have previously tested positive on a Lateral Flow Device (LFD).
IHPN wins “Best COVID-19 Crisis Response” award
The Independent Healthcare Providers Network (IHPN) has been announced as the winner of the “Best COVID-19 Crisis Response” at this year’s Association Excellence Awards which took place in Central London.
Clinical trialists to be offered 'top-up' vaccine doses
Vaccine clinical trial participants are to be offered the option to get additional vaccine doses from next week.
Why some individuals have stronger SARS-COV-2 defences
A new study has revealed important insights into the natural human antiviral defences against SARS-CoV-2, the virus that causes COVID-19.
New potential factor contributing to severity of COVID-19 identified
The University of Kent’s School of Biosciences and the Institute of Medical Virology at Goethe-University, Frankfurt am Main, have identified a protein that may critically contribute to severe forms of COVID-19.
Most vulnerable to be offered COVID-19 booster vaccines
Millions of vulnerable people are to be offered a COVID-19 booster vaccine from next week as the Government confirmed it has accepted the final advice from the independent Joint Committee on Vaccination and Immunisation (JCVI).
Antibody treatment reduces risk of symptomatic COVID-19 by 77%
An antibody treatment trialled at UCLH cuts the risk of developing symptomatic COVID-19 by 77%, according to results announced by AstraZeneca who developed the antibody known as AZD7442.
Study tests third COVID vaccine for weakened immune systems
A new clinical trial will investigate whether a third dose of vaccine for people with weakened immune systems gives a stronger immune response than two doses.
Government launches UK-wide antibody surveillance programme
Thousands of adults a day will be given free access to antibody tests through a new national surveillance programme launched by the UK Health Security Agency.
Latest Issues
MMM has been operating worldwide as one of the leading system providers in the service of health since 1954. With a full portfolio of products and services pertaining to sterilization & disinfection systems for hospitals, scientific institutes, laboratories & the pharmaceutical industry, MMM has positioned itself as a crucial quality driver.
AfPP Plymouth Regional Conference
TBC, Plymouth
10th May 2025
Association of Continence Professionals Annual Conference and Networking Exhibition 2025
Kents Hill Park, Milton Keynes
19th - 20th May 2025
Theatres and Decontamination Conference
CBS Arena
20th May 2025
British Infection Association 27th Annual Clinical and Scientific Meeting 2025
Hilton, Newcastle Gateshead
20th - 21st May 2025
BAUN Day Educational Event
Hilton, Belfast
6th June 2025
EBME Expo 2025
Coventry Building Society Arena, UK
25th - 26th June 2025